Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Return on Equity (2021 - 2025)

Cytek Biosciences' Return on Equity history spans 5 years, with the latest figure at 0.18% for Q4 2025.

  • For Q4 2025, Return on Equity fell 17.0% year-over-year to 0.18%; the TTM value through Dec 2025 reached 0.18%, down 17.0%, while the annual FY2025 figure was 0.18%, 17.0% down from the prior year.
  • Return on Equity reached 0.18% in Q4 2025 per CTKB's latest filing, down from 0.03% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.01% in Q3 2021 to a low of 1.69% in Q1 2021.
  • Average Return on Equity over 5 years is 0.18%, with a median of 0.02% recorded in 2024.
  • Peak YoY movement for Return on Equity: surged 169bps in 2022, then dropped -17bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.01% in 2021, then decreased by -21bps to 0.01% in 2022, then tumbled by -611bps to 0.03% in 2023, then surged by 48bps to 0.02% in 2024, then crashed by -1085bps to 0.18% in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Return on Equity are 0.18% (Q4 2025), 0.03% (Q3 2025), and 0.02% (Q2 2025).